Inhibitory effects and mechanisms of the anti-covid-19 traditional Chinese prescription, Keguan-1, on acute lung injury
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibitory effects and mechanisms of the anti-covid-19 traditional Chinese prescription, Keguan-1, on acute lung injury
Authors
Keywords
COVID-19, Keguan-1, ALI, Inflammation, Pulmonary vascular endothelial injury
Journal
JOURNAL OF ETHNOPHARMACOLOGY
Volume 285, Issue -, Pages 114838
Publisher
Elsevier BV
Online
2021-11-14
DOI
10.1016/j.jep.2021.114838
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection
- (2021) Stephany Beyerstedt et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Si-Wu-Tang facilitates ovarian function through improving ovarian microenvironment and angiogenesis in a mouse model of premature ovarian failure
- (2021) Fanru Zhou et al. JOURNAL OF ETHNOPHARMACOLOGY
- Traditional Chinese Medicine for COVID-19 Treatment
- (2020) Jun-ling Ren et al. PHARMACOLOGICAL RESEARCH
- Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
- (2020) Yingxia Liu et al. Science China-Life Sciences
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age
- (2020) Katarzyna Bilinska et al. ACS Chemical Neuroscience
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons
- (2020) Shivraj Hariram Nile et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Angiotensin‐converting enzyme‐2 ( ACE2 ), SARS‐CoV ‐2 and pathophysiology of coronavirus disease 2019 ( COVID ‐19)
- (2020) Arno R. Bourgonje et al. JOURNAL OF PATHOLOGY
- Endothelial cell infection and endotheliitis in COVID-19
- (2020) Zsuzsanna Varga et al. LANCET
- Severe Covid-19
- (2020) David A. Berlin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial
- (2020) Ke Hu et al. PHYTOMEDICINE
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- Exploring an Integrative Therapy for Treating COVID-19: A Randomized Controlled Trial
- (2020) Jia-bo Wang et al. Chinese Journal of Integrative Medicine
- Pathogenesis and Management of Myocardial Injury in Coronavirus Disease 2019
- (2020) Zhi‐Yao Wei et al. EUROPEAN JOURNAL OF HEART FAILURE
- Coronavirus breakthrough: dexamethasone is first drug shown to save lives
- (2020) Heidi Ledford NATURE
- Dexamethasone for COVID-19: data needed from randomised clinical trials in Africa
- (2020) Helen Brotherton et al. Lancet Global Health
- Combating COVID-19 with integrated traditional Chinese and Western medicine in China
- (2020) Liqiang Ni et al. Acta Pharmaceutica Sinica B
- Bioactive natural compounds against human coronaviruses: a review and perspective
- (2020) Yanfang Xian et al. Acta Pharmaceutica Sinica B
- COVID-19, Renin-Angiotensin System and Endothelial Dysfunction
- (2020) Razie Amraei et al. Cells
- SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19
- (2020) Si Zhang et al. Journal of Hematology & Oncology
- Systems pharmacological study illustrates the immune regulation, anti-infection, anti-inflammation, and multi-organ protection mechanism of Qing-Fei-Pai-Du decoction in the treatment of COVID-19
- (2020) Jing Zhao et al. PHYTOMEDICINE
- Pathogenesis of Acute Respiratory Distress Syndrome
- (2019) Laura Huppert et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Compound edaravone alleviates lipopolysaccharide (LPS)-induced acute lung injury in mice
- (2017) Zhengping Zhang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Alveolar macrophage-derived microvesicles mediate acute lung injury
- (2016) Sanooj Soni et al. THORAX
- Lipopolysaccharide Induces Alveolar Macrophage Necrosis via CD14 and the P2X7 Receptor Leading to Interleukin-1α Release
- (2015) Jargalsaikhan Dagvadorj et al. IMMUNITY
- Posttreatment with Ma-Xing-Shi-Gan-Tang, a Chinese Medicine Formula, Ameliorates Lipopolysaccharide-Induced Lung Microvessel Hyperpermeability and Inflammatory Reaction in Rat
- (2014) Li-Qian Ma et al. MICROCIRCULATION
- Neutrophils in acute lung injury
- (2012) Xiao et al. Frontiers in Bioscience-Landmark
- Unknown
- (2011) Jochen Grommes et al. MOLECULAR MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started